Life Image, a global network for sharing clinical and imaging data, today announced a new partnership with Mendel.ai, a novel AI platform built to turbocharge oncology clinical research, to support the adoption of AI in site selection and patient recruitment for clinical trials.
According to Accenture, AI-powered clinical trial identifier apps are expected to save the industry $13B by 2026. This strategic partnership between Life Image and Mendel addresses this demand by combining the power of Life Image’s global interoperable network of clinical data with Mendel’s novel AI capabilities, overcoming some of the biggest challenges in clinical research.
Life sciences organizations will be able to more efficiently pair patients and cohorts with oncology trials by leveraging Life Image’s global network, which improves access and search functionality of clinical data.
Life Image and Mendel.ai Integration Details
This new engagement will advance the use of Mendel Brain, which helps life sciences and research facilities by analyzing clinical data at a site location to identify patient cohorts for a given protocol. Mendel Brain yields 30 to 50 percent more patients while decreasing the elapsed time between patient eligibility and identification to minutes compared to conventional pre-screening practices, which can take months or even years. It can also proactively identify potential trials for patients by comparing their EMR data to an industry-leading trial database curated from over 40,000 sources.
Mendel Brain Offering with Life Image
Mendel Brain will be offered as a component of the Life Image Interoperability Suite to deliver additional value to its large network of research hospitals. With the depth and breadth of Life Image’s network of Academic Medical Centers (AMC), the Mendel Brain solution is in high demand to reduce the administrative burdens of clinical trial participation. In addition, the ease of interoperability and integration available through Life Image will help accelerate the adoption and application of Mendel Brain while providing greater access to clinical data including imaging data to help increase accuracy in patient selection.
Life Image Recent Re-launch
This new partnership follows Life Image’s recent re-launch announcement, which included the release of its new Interoperability Suite. Life Image’s interoperable solution, which integrates into existing workflows, orchestrates the flow of more than 10 million clinical encounters per month, connecting 1,500 U.S. facilities, 8,000 affiliated sites, 150,000 U.S. providers, and 58,000 global clinics with a broader ecosystem of patients, life sciences, medical device companies, and telehealth companies.
“Assembling clinical trials has long posed significant challenges for both our core customers as well as the healthcare industry as a whole,” said Matthew A. Michela, President and CEO, Life Image. “EHRs, imaging, lab, and other systems in the clinical setting have the information we need to find the most appropriate patient cohorts, but that data needs to be interoperable and searchable to have utility. This important partnership with Mendel allows us to offer our network, interoperability, and imaging expertise to augment Mendel Brain. Additionally, our large market penetration with research-oriented health systems will help make this leading solution available to easily integrate it within a hospital’s systems. Mendel Brain and our interoperable global network, together, will help us leap ahead in our quest to solve another of healthcare’s biggest challenges.”
